Piramal Enterprises has received an approval for the allotment of 1,750 Secured, Rated, Listed, Redeemable Principal Protected, Market Linked Non-Convertible Debentures (NCDs) each having a face value of Rs 10,00,000, at a further issue price of Rs 10,05,497 per Debenture, aggregating to Rs 175.96 crore on private placement basis. These Debentures are proposed to be listed on the Debt Segment and Capital Market Segment of National Stock Exchange of India (NSE) and BSE respectively, and NSE being the designated Stock Exchange. The Meeting of Administrative Committee (Committee) of the Board of Directors of the Company held on March 28, 2022, has approved the allotment of the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
